"Hemolysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Descriptor ID |
D006461
|
| MeSH Number(s) |
C23.550.403 G12.122.545
|
| Concept/Terms |
Extravascular Hemolysis- Extravascular Hemolysis
- Extravascular Hemolyses
- Hemolyses, Extravascular
- Hemolysis, Extravascular
Intravascular Hemolysis- Intravascular Hemolysis
- Hemolyses, Intravascular
- Hemolysis, Intravascular
- Intravascular Hemolyses
|
Below are MeSH descriptors whose meaning is more general than "Hemolysis".
Below are MeSH descriptors whose meaning is more specific than "Hemolysis".
This graph shows the total number of publications written about "Hemolysis" by people in this website by year, and whether "Hemolysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1997 | 0 | 3 | 3 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 2 | 2 |
| 2011 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 4 | 1 | 5 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemolysis" by people in Profiles.
-
Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease. Proc Natl Acad Sci U S A. 2022 08 23; 119(34):e2207592119.
-
A Novel Full-Length Recombinant Human Complement Factor H (CFH; GEM103) for the Treatment of Age-Related Macular Degeneration Shows Similar In Vitro Functional Activity to Native CFH. Curr Eye Res. 2022 07; 47(7):1087-1093.
-
Complement C5 inhibition protects against hemolytic anemia and acute kidney injury in anthrax peptidoglycan-induced sepsis in baboons. Proc Natl Acad Sci U S A. 2021 09 14; 118(37).
-
Hemolysis estimation in turbulent flow for the FDA critical path initiative centrifugal blood pump. Biomech Model Mechanobiol. 2021 Oct; 20(5):1709-1722.
-
Production of erythrocyte microparticles in a sub-hemolytic environment. J Artif Organs. 2021 Jun; 24(2):135-145.
-
COVID-19 related immune hemolysis and thrombocytopenia. J Med Virol. 2021 02; 93(2):1164-1170.
-
1, 3ß-Glucan anchored, paclitaxel loaded chitosan nanocarrier endows enhanced hemocompatibility with efficient anti-glioblastoma stem cells therapy. Carbohydr Polym. 2018 Jan 15; 180:365-375.
-
Successful kidney transplantation in a patient with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome). Transfusion. 2017 12; 57(12):3058-3062.
-
High Hemoglobin Is an Independent Risk Factor for the Development of Hemolysis During Pediatric Extracorporeal Life Support. J Intensive Care Med. 2019 Mar; 34(3):259-264.
-
Flow-Field Simulations and Hemolysis Estimates for the Food and Drug Administration Critical Path Initiative Centrifugal Blood Pump. Artif Organs. 2017 Oct; 41(10):E129-E140.